small molecule

LO LOESTRIN FE

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Loss of exclusivityFebruary 2029latest FDA-listed patent expiry
CompanyALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Drug detail

Brand nameLO LOESTRIN FE
Active ingredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Strength0.01MG,0.01MG;1MG,N/A
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2010
Marketing statusRX

Listed patents

PatentExpiresType
7704984February 2029use U-1090

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LO LOESTRIN FE patent cliff — loss of exclusivity February 2029 | CliffBio